ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
Dow Jones
38.686,32
1,51%
Euro vs US Dollar
1,08565
0,00%
Bitcoin
67.792,75
0,10%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Rexahn Pharmaceuticals Inc (REXN)

  7. Rexahn Pharmaceuticals Inc (REXN) News

REXN

Rexahn Pharmaceuticals (REXN)

Rexahn Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:REXN
DatumZeitQuelleÜberschriftSymbolFirma
14/06/202322h32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
09/06/202312h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
09/06/202300h49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
02/06/202322h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
15/05/202314h23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:REXNRexahn Pharmaceuticals Inc
15/05/202314h08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
01/05/202322h16Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:REXNRexahn Pharmaceuticals Inc
01/05/202322h13Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:REXNRexahn Pharmaceuticals Inc
21/04/202314h11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
05/04/202323h05Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:REXNRexahn Pharmaceuticals Inc
30/03/202323h08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
30/03/202315h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
14/02/202320h04Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:REXNRexahn Pharmaceuticals Inc
25/01/202322h17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
13/01/202300h09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
12/01/202323h38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
12/01/202323h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
12/01/202323h29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
06/01/202315h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
06/12/202212h37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
07/11/202222h17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
20/10/202222h02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
14/10/202217h33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
04/10/202215h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
08/09/202222h02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
12/08/202223h02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:REXNRexahn Pharmaceuticals Inc
12/08/202213h53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
07/07/202200h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
06/07/202223h59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
06/07/202223h49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:REXN

Kürzlich von Ihnen besucht

NYSE
NKE
Nike
DBI
SDXP
SDAX
NASDAQ
TSLA
Tesla
NYSE
XOM
Exxon Mobil
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
XLV
Health Care Select Sector
AMEX
XLF
Financial Select Sector
NYSE
DIS
Walt Disney
FX
EURGBP
Euro vs Sterling
DBI
MDAX
MDAX
NASDAQ
NVDA
NVIDIA
TG
DTE
Deutsche Telekom
USOTC
BNPQY
BNP Paribas (QX)
TG
432
Arbor Metals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten